Guerin Mark Patrick 4
4 · Onconova Therapeutics, Inc. · Filed Aug 4, 2023
Insider Transaction Report
Form 4
Guerin Mark Patrick
Chief Accounting Officer
Transactions
- Exercise/Conversion
Common Stock
2023-08-02+4,750→ 26,866 total - Tax Payment
Common Stock
2023-08-03$1.02/sh−1,422$1,450→ 25,444 total - Exercise/Conversion
Restricted Stock Units
2023-08-02−4,750→ 4,750 total→ Common Stock (4,750 underlying)
Footnotes (2)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On August 2, 2021 the reporting person was granted 14,250 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary.